Arcutis Biotherapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Arcutis Biotherapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Arcutis Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $241K, a 36.9% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $965K, a 23.6% increase from 2022.
  • Arcutis Biotherapeutics, Inc. annual Operating Lease, Payments for 2022 was $781K, a 585% increase from 2021.
  • Arcutis Biotherapeutics, Inc. annual Operating Lease, Payments for 2021 was $114K, a 40.6% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $965K +$184K +23.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $781K +$667K +585% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $114K -$78K -40.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $192K +$51K +36.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $141K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.